-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BxJxBITytIhpj9O6JpY3qR2ihSw+qXYrEolyCPvEE4yzdbmZBzb/zc6pWLwrgQmb QjqKwj+0So83VXEHQscTCg== 0001014739-09-000039.txt : 20090910 0001014739-09-000039.hdr.sgml : 20090910 20090910104027 ACCESSION NUMBER: 0001014739-09-000039 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090908 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090910 DATE AS OF CHANGE: 20090910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioScrip, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28740 FILM NUMBER: 091061899 BUSINESS ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 BUSINESS PHONE: 914 460 1600 MAIL ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 8-K 1 form8krsappoinment.htm FORM 8-K RICK SMITH APPOINTMENT form8krsappoinment.htm
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.

______________________________________________


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 
 
Date of Report (Date of earliest event reported): September 8, 2009
 
 

BioScrip, Inc.
(Exact Name of Registrant as Specified in its Charter)

 
 
Delaware
0-28740
05-0489664
(State or Other Jurisdiction of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)



100 Clearbrook Road, Elmsford, New York
10523
(Address of Principal Executive Offices)
(Zip Code)

 
Registrant’s telephone number, including area code (914) 460-1600


________________________________________________________________________
(Former Name or Former Address, if Changed Since Last Report)
 

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
¨  Written communications pursuant to Rule 425 under the Section Act (17 CFR 230.425)
 
 
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
 
 
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
 
 
¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
 

 
 
 

Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
 
Effective September 8, 2009, the Board of Directors (the “Board”) of BioScrip, Inc. (the “Company”) increased the size of the Board from eight to nine directors and appointed Richard M. Smith to the Board in order fill the vacancy created thereby.  Mr. Smith will hold such office until the Company’s next annual meeting of stockholders or until his successor shall be elected and qualified.  Mr. Smith currently serves as the Company’s President and Chief Operating Officer.
 
 
The Board did not appoint Mr. Smith pursuant to any arrangements or understandings between Mr. Smith and the Company or any other person. There are no material transactions between Mr. Smith and the Company.
 

 
2
 

SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.
 

 

 

 
Date:  Septmebr 10, 2009
BIOSCRIP, INC.
 
 
 
 
By:
/s/ Barry A. Posner                                                                
Barry A. Posner, Executive Vice President

 

 
3
 

-----END PRIVACY-ENHANCED MESSAGE-----